Rentschler Biopharma, a global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), has announced that it will construct a new buffer media station at its company headquarters in Laupheim, Germany.

The new facility aims to further increase production efficiency and modernise the site to support evolving requirements of clients. The facility, which will cover 3,400 square meters, will be integrated with the existing infrastructure to offer faster and more efficient processes, as well as ergonomically designed workstations, and will include three media tanks and six buffer tanks, providing sufficient space and capacity for the production of buffer solutions and media. Construction is scheduled to start in spring 2025, with completion and operational launch planned by the end of 2027.